Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Yael C. Cohen, Hila Magen, Noa Lavi, Moshe E. Gatt, Evgeni Chubar, Nethanel Horowitz, Natalia Kreiniz, Tamar Tadmor, Svetlana Trestman, Roy Vitkon, Ory Rouvio, Olga Shvetz, Adir Shaulov, Tomer Ziv-Baran, Irit Avivi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study'. Together they form a unique fingerprint.

Medicine & Life Sciences